Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

ExCellThera secures German NUB Status 1 listing for Zemcelpro

Summary by Pharmaceutical-technology.com
ExCellThera, along with its wholly owned subsidiary Cordex Biologics, has received Status 1 listing from the NUB programme in Germany for Zemcelpro,
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

3 Articles

Verdict HospitalVerdict Hospital
+2 Reposted by 2 other sources

ExCellThera secures German NUB Status 1 listing for Zemcelpro

ExCellThera, along with its wholly owned subsidiary Cordex Biologics, has received Status 1 listing from the NUB programme in Germany for Zemcelpro,The post ExCellThera secures German NUB Status 1 listing for Zemcelpro appeared first on Hospital Management.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Tuesday, February 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Germany icon

Germany

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal